Hakluyt Capital announces three of its first investments
Interos' AI-powered platform is helping the world's leading multinational corporations, governments, and other organisations map, monitor and pre-empt emerging and systemic risks hidden deep in manufacturing and cyber supply chains to protect brand, reputation and profitability.
CalypsoAI is a leading AI Security company empowering international organisations to leverage generative AI and Large Language Models (LLMs) safely and confidently. The company's platform is designed to mitigate the risks posed by generative AI models, providing industry-leading safeguards that prevent the leakage of sensitive data and block malicious attacks.
Viz.ai's software platform harnesses AI to accelerate the diagnosis and treatment of serious illnesses. Its algorithms, which have been cleared by the US Food and Drug Administration (FDA), analyse medical imaging data such as CT scans and electrocardiograms to support medical professionals with real-time insights and assessments.
Hakluyt Capital invests alongside leading venture capital funds, and targets Series B to D companies with international ambitions and high growth potential. Hakluyt Capital is a value-added investor: the firm's in-house team across the
Speaking about Hakluyt Capital's first investments,
On Hakluyt Capital's investment in Interos, founder and CEO
Dr
Notes to editors
Hakluyt Capital, which was founded in 2023, invests alongside leading venture capital funds, targeting Series B to D companies with high growth potential and international ambitions. Its parent company, Hakluyt, is a strategic advisory firm that works with corporate leaders and investors around the world on their most important commercial issues.
For more information on the fund, please visit www.hakluytcapital.com.
For more information on Hakluyt, please visit www.hakluytandco.com.
View original content:https://www.prnewswire.com/news-releases/hakluyt-capital-announces-three-of-its-first-investments-302020142.html
SOURCE Hakluyt
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HTX Research Examines U.S. AI Equities: Technology Remains Early, While Capital Expenditure and Valuations Have Entered the Late Cycle
- Solana Price Prediction: Could SOL Reclaim Its $295 High as AlphaPepe Presale Nears Its Biggest Launch Catalysts?
- Norton Manx R Earns Landmark International Design Excellence Award for Reimagining the Superbike
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share